Heterozygous Germline ATM Mutations Do Not Contribute to Radiation-Associated Malignancies After Hodgkin's Disease PURPOSE: To examine the safety, efficacy, costs, and impact on quality of life of ...
This study enrolled oncology and hematology patients who had retained their port following completion of anticancer treatment. Clinical data were extracted for 1,059 participants. The primary end ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results